Abstract Background and Objectives Cognitive disorders may be an early sign of
neuropsychiatric disorders; however, it remains unclear whether the screening measures …

In the current era of therapy for human immunodeficiency virus (HIV), life expectancy for
persons living with HIV (PLWH) approaches that of the general population. This newly …

Despite the recent advances in HIV treatment, HIV-associated neurocognitive disorder
(HAND) prevalence remains high, especially in the mild forms. Current recommendations …

This study aims to systematically review the evidence on the accuracy of the Montreal
Cognitive Assessment (MoCA) test for diagnosing HIV–associated neurocognitive disorders …

The modern combined antiretroviral treatment (cART) for human immunodeficiency virus
(HIV) infection has substantially lowered the incidence of HIV-associated dementia (HAD) …

The present study aims to systematically review the evidence on the accuracy of the
International HIV Dementia Scale (IHDS) test for diagnosing human immunodeficiency virus …

Although the combination antiretroviral treatment (cART) has considerably lowered the risk
of HIV associated dementia (HAD), the incidence of neurocognitive impairments (NCI) has …

The continuing increase in patient numbers and improvement in healthcare provisions of
HIV services in the UK, alongside the effectiveness of combined antiretroviral therapy …

Objective: Prevention and treatment of dementia is a global concern that requires
involvement of international samples. The purpose of this study is to develop culturally …

Aging and increased cardiovascular risk are major drivers for HIV-associated neurocognitive
disorders (HAND), for which accurate screenings are lacking. Mini-Addenbrooke's Cognitive …